Effect of physicochemical properties of biodegradable polymers on nano drug delivery

Polymer Reviews

Volumn 53, Issue 4, 2013, Pages 546-567

  Sonam, S ^a   Chaudhary, Hema ^a   Arora, Vimal ^b   Kholi, Kanchan ^c   Kumar, Vikash ^a  

^a PDM College of Pharmacy   (India)

^b CT Group of Institutions   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Biodegradable polymers; drug release; nano drug delivery; physicochemical properties

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; BIOCOMPATIBLE POLYMER; BIOLOGICAL EFFICIENCY; DELIVERY SYSTEMS; DRUG DELIVERY SYSTEM; DRUG RELEASE; PHYSICOCHEMICAL PROPERTY; THERAPEUTIC AGENTS;

BIOCOMPATIBILITY; DRUG DELIVERY; DRUG PRODUCTS; FUNCTIONAL POLYMERS;

BIODEGRADABLE POLYMERS;

EID: 84885592960     PISSN: 15583724     EISSN: 15583716     Source Type: Journal    
DOI: 10.1080/15583724.2013.828751     Document Type: Article

References (93)

1. Mishra, N.; Goyal, A. K.; Khatri, K.; Vaidya, B.; Paliwal, R.; Rai, S.; Mehta, A.; Tiwari, S.; Vyas, S. "Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides", Antiinflamm. Antiallergy Agents Med. Chem. 2008, 7(4), 240-251.
2. Janes, K. A.; Calvo, P.; Alonso, M. J. "Polysaccharide colloidal particles as delivery systems for macromolecules", Adv. Drug Deliver. Rev. 2001, 47(1), 83-97.
3. Kumari, A.; Yadav, S. K.; Yadav, S. C. "Biodegradable polymeric nanoparticles based drug delivery systems", Colloids Surface B: Biointerfaces. 2010, 75, 1-18.
4. Mittal, G.; Sahana, D. K.; Bhardwaj, V.; Kumar, R. M. N. "Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer weight and copolymer composition on release behavior in vitro and in vivo", J. Control. Release 2007, 119, 77-85.
5. Lü, J. M.; Wang, X.; Muller, C. M.; Wang, H.; Lin, P. H.; Yao, Q.; Chen, C. "Current advances in research and clinical applications of PLGA based nanotechnology", Expert Rev. Mol. Diagn. 2009, 9(4), 325-341.
6. Okada, H. "One and three month release injectable microspheres of the LH-RH superagonists leuprorelin acetate", Adv. Drug Deliver. Rev. 1997, 28, 43-70.
7. Danhier, F.; Ansorena, E.; Silva, J. M.; Coco, R.; Breton, A. L.; Préat, V. PLGA-based nanoparticles: An overview of biomedical applications. J. Control. Release 2012, 161, 505-522.
8. Park, J. H.; Saravanakumar, G.; Kim, K.; Kwon, I. C. "Targeted delivery of low molecular drugs using chitosan and its derivatives", Adv. Drug Deliver. Rev. 2010, 62(1), 28-41.
9. Dash, T. K.; Konkimalla, V. B. "Poly-ε-caprolactone based formulation for drug delivery and tissue engineering: A review", J. Control. Release 2012, 158, 15-33.
10. Hunter, A. C.; Elsom, J.; Wibroe, P. P.; Moghimi, S. M. "Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective", Nanomedicine. 2012, 8, S5-S20.
11. Parveen, S.; Misra, R. "Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging", Nanomedicine. 2012, 8, 147-166.
12. Bagul, R.; Mahajan, V.; Dhake, A. "New approaches in nanoparticulate drug delivery system: A review", Int. J. Curr. Pharm. Res. 2012, 4(3), 29-38.
13. Jain, R. A. "The manufacturing techniques of various drug loaded biodegradable Poly(lactideco- glycolide) (PLGA) devices", Biomaterials. 2000, 21, 2475-2490.
14. Majeti, N. V.; Kumar, R. "Nano and microparticles as controlled drug delivery devices", J. Pharm. Pharm. Sci. 2000, 3(2), 234-258.
15. Kumar, P.; Meena, K. P.; Kumar, P.; Choudhary, C.; Thakur, D. S.; Bajpayee, P. "Dendrimer: A novel polymer for drug delivery", J. Innovative Trends in Pharma. Sci. 2010, 1(6), 252-269.
16. Peracchia, M. T.; Fattal, E.; Desmaele, D.; Besnard, M.; Neol, J. P.; Gomis, J. M.; Apple, M.; d'Angelo, J.; Couvreur, P. 'stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting", J. Control. Release 1999, 121-128.
17. Vij, N.; Min, T.; Marasigan, R.; Belcher, C. N.; Mazur, S.; Ding, H.; Yong, K. T.; Roy, I. "Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis", J. Nanobiotech. 2010, 8, 22.
18. Lai, S. K.; Wang, Y. Y.; Hanes, J. "Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues", Adv. Drug Deliver. Rev. 2009, 61, 158-171.
19. Dinarvand, R.; Sepehri, N.; Manoochehri, S.; Rouhani, H.; Atyabi, F. "Poly(lactide-co-glycolide) nanoparticles for controlled delivery of anticancer agents", Int. J. Nanomedicine. 2011, 6, 877-895.
20. Meredith, L.; Lowman, Hans; Lowman, A. M. "Nanoparticles for drug delivery". In Nanomaterials Handbook, Ch. 23; 2006.
21. Makadia, H. K.; Siegel, S. J. "Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier", Polymers. 2011, 3, 1377-1397.
22. Vandana, M.; Sahoo, S. K. "Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer", Biomaterials. 2010, 3, 9340-9356.
23. Shenoy,D. B.; Amiji, M. M. "Poly(ethylene oxide)-modified poly(epsiloncaprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer", Int. J. Pharm. 2005, 293(1-2), 261-270.
24. Ven, H. V. D.; Vermeersch, M.; Matheeussen, A.; Vandervoort, J.; Weyenberg, W.; Aspers, S.; Cos, P.; Maes, L.; Ludwig, A. "PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: Factor influence study and in vitro efficacy evaluation", Int. J. Pharm. 2011, 420, 122-132.
25. Kim, B. K.; Hwang, S. J.; Park, J. B. "Characteristics of felodipine-located poly (e-caprolactone) microspheres", J. Microencapsul. 2005, 22(2), 193-203.
26. Mohammadi, G.; Valizadeh, H.; Barzegar-jalali, M.; Lotfipour, F.; Adibkia, K.; Milani, M.; Azhdarzadeh,M.; Kiafar, F.; Nokhodchi,A. "Development of azithromycin-PLGA nanoparticles: Physicochemical characterisation and antibacterial effect against Salmonella typhi", Colloids Surface B Biointerfaces. 2010, 80, 34-39.
27. Kumar, G.; Sharma, S.; Shafiq, N.; Khuller, G. K.; Malhotra, S. "Optimization, in vitro-in vivo evaluation: Short-term tolerability of novel levofloxacin-loadedPLGAnanoparticle formulation", J. Pharm. Sci. 2012, 101(6), 2165-2176.
28. Silva, L. C. D.; Garcia, T.; Mori, M.; Sandri, G.; Bonferoni, M. C.; Finotelli, P. V.; Cinelli, L. P.; Caramella, C.; Cabral, L. M. "Preparation and characterization of Polysaccheride-based Nanoparticles with anticoagulant activity", Int. J. Nanomedicine. 2012, 7, 2975-2986.
29. Kumar, M. N.; Muzzarelli, R. A.; Muzzarelli, C.; Sashiwa, H.; Domb, A. J. "Chitosan chemistry and pharmaceutical perspective", Chem Rev. 2004, 104(12), 6017-6184.
30. Bei, Y. Y.; Chen, X. Y.; Liu, Y.; Xu, J. Y.; Wang, W. J.; Gu, Z. L.; Xing, K. L.; Zhu, A. J.; Chen, W. L.; Shi, L. S.; Wang, Q.; Zhang, X. N.; Zhang, Q. "Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption", Int. J. Nanomedicine. 2012, 7, 1819-1827.
31. Rao, J. P.; Geckeler, K. E. "Polymeric nanoparticles: Preparation techniques and size-control parameters", Prog. Polym. Sci. 2011, 36, 887-913.
32. Joshi, S. A.; Chavhan, S. S.; Sawant, K. K. "Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies", Eur. J. Pharm. Biopharm. 2010, 76, 189-199.
33. Nikouei, B. M.; Tabassi, S. A. S.; Jaafari, M. R. "The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A", Curr. Drug Del. 2006, 3(4), 343-349.
34. Panyam, J.;Williams, D.; Dash, A.; Pelecky, D. L.; Labhasetwar, V. 'solid-state solubility influences encapsulation and release of hydrophobic drugs from plga/pla nanoparticles", J. Pharm. Sci. 2004, 93(7), 1804-1814.
35. Zambaux, M. F.; Bonneaux, F.; Gref, R.; Dellacherie, E.; Vigneron, C. "Preparation and characterization of protein C-loaded PLA nanoparticles", J. Control. Release 1999, 60(2-3), 179-188.
36. Matsumoto, J.; Nakada, Y.; Sakurai, K.; Nakamura, T.; Takahashi, Y. "Preparation of nanoparticles consisted of poly(llactide)-poly(ethylene glycol)-poly(l-lactide) and their evaluation in vitro", Int. J. Pharm. 1999, 185(1), 93-101.
37. Tsai, Y. M.; Liao, W. L. C.; Chien, C. F.; Lin, L. C.; Tsai, T. H. "Effects of polymer molecular weight on relative oral bioavailability of curcumin", Int. J. Nanomedicine. 2012, 7, 2957-2966.
38. Feng, R.; Song, Z.; Zhai, G. "Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles", Int. J. Nanomedicine. 2012, 7, 4089-4098.
39. Hans, M. L.; Lowman, A. M. "Biodegradable nanoparticles for drug delivery and targeting", Curr. Opin. Solid State Mater. Sci. 2002, 6, 319-327.
40. Liu, Y.; Zang, H. D.; Kong, M.; Ma, F. K.; Dang, Q. F.; Cheng, X. J.; Ji, Q. X.; Chen, X. G. "In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles", Carbohydr. Polymer 2012, 89, 453-460.
41. Park, K.; Kim, J. H.; Nam, Y. S.; Lee, S.; Nam, H. Y.; Kim, K.; Park, J. H.; Kim, I. S.; Choi, K.; Kim, S. Y.; Kwon, I. C. "Effect of polymer molecular weight on the tumor targeting characteristics of self- assembled glycol chitosan nanoparticles", J. Control. Release 2007, 122, 305-314.
42. Youan, B. B. C.; Benoit, M. A.; Baras, B.; Gillard, J. "Protein -loaded poly (ε-caprolactone) microparticles I. Optimization of the preparation by (water -in -oil)-in water emulsion solvent evaporation", J. Microencapsul. 1999, 16(5), 587-599.
43. Santos, K. C. D.; Silva, M. F.; Pereira-Filho, E. R.; Fernandes, J. B.; Polikarpov, I.; Forim, M. R. "Polymeric nanoparticles loaded with the 3,5,3′-triidothyroacetic acid (Triac), a thyroid hormone: Factorial design, characterisation, and release kinetics", Nanotech. Sci. Appl. 2012, 5, 37-48.
44. Zolnik, B. S.; Burgess, D. J. "Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres", J. Control. Release 2008, 127, 137-145.
45. Eldridge, J. H.; Hammond, C. J.; Meulbroek, J. A.; Staas, J. K.; Gilley, R. M.; Tice, T. R. "Controlled vaccine release in the gut-associated lymphoid-tissues-Orally administered biodegradable microspheres target the Peyer's patches", J. Control. Release 1990, 11, 205-214.
46. Reis, C. P.; Neufeld, R. J.; Ribeiro, A. J.; Veiga, F. "Nanoencapsulation I. Method of preoaration of drug-loaded polymeric nanoparticles", Nanomedicine: Nanotech. Biol. and Medicine 2006, 2, 8-21.
47. Bilensoy, E.; Sarisozen, C.; Esendaǧli, G.; Doǧan, A. L.; Aktas, Y.; Sen, M.; Mungan, N. A. "Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors", Int. J. Pharm. 2009, 371, 170-176.
48. Derakhshandeh, K.; Erfan, M.; Dadashzadeh, S. "Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics", Eur. J. Pharm. Biopharm. 2007, 66, 34-41.
49. Abdelghany, S. M.; Quinn, D. J.; Ingram, R. J.; Gilmore, B. F.; Donnelly, R. F.; Taggart, C. C.; Scott, C. J. "Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa", Int. J. Nanomedicine. 2012, 7, 4053-4063.
50. Zaki, N. M.; Hafez, M. M. "Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium", AAPS PharmSciTech. 2012, 13(2), 411-421.
51. Jeong, Y. I.; Na, H. S.; Seo, D. H.; Kim, D. G.; Lee, H. C.; Jang, M. K.; Na, S. K.; Roh, S. H.; Kim, S. I.; Nah, J. W. "Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity", Int. J. Pharm. 2008, 352, 317-323.
52. Osuna, I. B.; Vauthier, C.; Farabollini, A.; Palmieri, G. F.; Ponchel, G. "Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles", Biomaterials 2007, 28, 2233-2243.
53. Owens, D. E.; Peppas, N. A. "Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticle", Int. J. Pharm. 2006, 307, 93-102.
54. Tahara, K.; Sakai, T.; Yamamoto, H.; Takeuchi, H.; Hirashima, N.; Kawashima, Y. "Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells", Int. J. Pharm. 2009, 382, 198-204.
55. Patil, Y. B.; Swaminathan, S. K.; Sadhukha, T.; Ma, L.; Panyam, J. "The use of nanoparticlemediated targeted gene silencing and drug delivery to overcome tumor drug resistance", Biomaterials 2010, 31, 358-365.
56. Araujo, J.; Vega, E.; Lopes, C.; Egea, M. A.; Garcia, M. L.; Souto, E. B. "Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres", Colloids Surf B Biointerfaces 2009, 72, 48-56.
57. Vega, E.; Gamisans, F.; Garc, M. L.; Chauvet, A.; Lacoulonche, F.; Egea, M. A. "PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions", J. Pharm. Sci. 2008, 97, 5306-5531.
58. Mittal, V. V.; Patel, S. J.; Sheth, S. K. "Development and characterization of folate targeted nanoparticle drug delivery system", Int. J. Pharma Bio. Sci. 2010, 1(2), 1-12.
59. Wang, Z.; Liu, W.; Huibi, X. U.; Yang, X. "Preparation and in vitro studies of stealth PEGylated PLGA nanoparticles as carriers for arsenic trioxide", Chin. J. Chem. Eng. 2007, 15(6), 795-801.
60. Sheng, Y.; Liu, C.; Yuan, Y.; Tao, X.; Yang, F.; Shan, X.; Zhou, H.; Xu, F. "Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan", Biomaterials. 2009, 30, 2340-2348.
61. Nguyen, J.; Reul, R. "Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improved transfection efficency to lung cells", J. Control. Release 2009, 140, 47-54.
62. Zabaleta, V.; Ponchel, G.; Salman, H.; Agueros, M.; Vauthier, C.; Irache, J. M. "Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study", Eur. J. Pharm. Biopharm. 2012, 81, 514-523.
63. Park, J.; Fong, P. M.; Lu, J.; Russell, K. S.; Booth, C. J.; Saltzman, W. M.; Fahmy, T. M. "PEGylated PLGA nanoparticles for the improved delivery of doxorubicin", Nanomedicine: Nanotech. Biol. and Medicine 2009, 5, 410-418.
64. Semete, B.; Booysen, L.; Kalombo, L.; Ramalapa, B.; Hayeshi, R.; Swai, H. S. "Effects of protein binding in the biodistribution of PEGylated PLGA nanoparticles post oral administration", Int. J. Pharm. 2012, 424, 115-120.
65. Chung, Y.; Chul, J.; Kim, Y. H.; Tae, G.; Lee, S. W.; Kim, K.; Kwon, I. "The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronics on tumor targeting", J. Control. Release 2010, 143, 374-382.
66. Roy, K.; Mao, H. Q.; Huang, S. K.; Leong, K. W. "Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy", Nat. Med. 1999, 5, 387-391.
67. Park, J. H.; Saravanakumar, G.; Kim, K.; Kwon, I. C. "Targeted delivery of low molecular drugs using chitosan and its derivatives", Adv. Drug Deliver. Rev. 2010, 62, 28-41.
68. Takeuchi, H.; Thongborisute, J.;Matsui, Y.; Sugihara, H.; Yamamoto, H.; Kawashima, Y. "Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems", Adv. Drug Deliver. Rev. 2005, 57, 1583-1594.
69. Hosseinzadeh, H.; Atyabi, F.; Dinarvand, R.; Ostad, S. N. "Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: Preparation and in vitro study", Int. J. Nanomedicine. 2012, 7, 1851-1863.
70. Swami, A.; Shi, J.; Gadde, S.; Votruba, A. R.; Kolishetti, N.; Farokhzad, O. C. "Nanoparticles for targeted and temporally controlled drug delivery". InMultifunctional Nanoparticles for Drug Delivery Applications: Imaging, Targeting, and Delivery, Chapter 2; Sonke, S., Robert, K. P., Eds. New York: Springer.
71. Ahsan, F.; Rivas, I. P.; Khan, M. A.; Suárez, A. I. T. "Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages", J. Control. Release 2002, 79(1-3), 29-40.
72. Salvador-Morales, C.; Zhang, L.; Langer, R.; Farokhzad, O. C. "Immuno-compatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups", Biomaterials. 2009, 30(12), 2231-2240.
73. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. "Factors affecting the clearance and bio-distribution of polymeric nanoparticles", Mol. Pharm. 2008, 5(4), 505-515.
74. Vasir, J. K.; Labhasetwar, V. "Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles", Biomaterials. 2008, 29, 4244-4252.
75. Foged, C.; Brodin, B.; Frokjaer, S.; Sundblad, A. "Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model", Int. J. Pharm. 2005, 298, 315-322.
76. Xua, F.; Yuana, Y.; Shana, X. "Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges", Int. J. Pharm. 2009, 377, 199-206.
77. Armstead,A. L.; Li, B. "Nanomedicine as an emerging approach against intracellular pathogens", Int. J. Nanomedicine. 2011, 6, 3281-3293.
78. Panyam, J.; Zhou,W. Z.; Prabha, S.; Sahoo, S. K.; Labhasetwar, V. "Rapid endolysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery", FASEB J. 2002, 16, 1217-1226.
79. Liu, J.; Xu, L. "Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake", Carbohydr. Polym. 2012, 90, 16-22.
80. Mohammadi, G.; Nokhodchi, A.; Jalali, M. B.; Lotfipour, F.; Adibkia, K.; Ehyaei, N.; Valizadeh, H. "Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system", Colloids Surf B Biointerfaces 2011, 88, 39-44.
81. Nahar, M.; Mishra, D.; Dubey, V.; Jain, N. K. "Development of Amphotericin B Loaded PLGA Nanoparticles for Effective Treatment of Visceral Leishmaniasis", Thirteenth International Conference on Biomedical Engineering, IFMBE Proceedings 2009; Vol. 23, pp 1241-1243.
82. Mao, S.; Xu, J.; Cai, C.; Germershaus, O.; Schaper, A.; Kissel, T. "Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres", Int. J. Pharm. 2007, 334(1-2), 137-148.
83. Thomasin, C.; Ho, N. T.; Merkle, H. P.; Gander, B. "Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics: Overviewand theoretical considerations", J. Pharm. Sci. 1998, 87(3), 259-268.
84. Park, T.G. "Degradation of poly (lactic-co-glycolic acid) microspheres: Effect of copolymer composition", Biomaterials 1995, 16(15), 1123-1130.
85. Sinha, V. R.; Trehan, A. "Development, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres as a depot system for parenteral delivery", Drug Deliv. 2008, 15(6), 365-372.
86. Vivek, K.; Reddy, L. H.; Murthy, R. S. "Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres", Pharm. Dev. Technol. 2007, 12(1), 79-88.
87. Sung, K. C.; Han, R. Y.; Hu, O. Y. P.; Hsu, L. R. "Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition", Int. J. Pharm. 1998, 172, 17-25.
88. Chem 421: Introduction to Polymer Chemistry, Polymer Properties and MW. (http://chem.chem.rochester.edu/~chem421/propsmw.htm, (Accessed online Jan 2013).
89. Karavelidis, V.; Giliopoulos, D.; Karavas, E.; Bikiaris, D. "Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior", Eur. J. Pharm. Sci. 2010, 41, 636-643.
90. Wu, X. S. 'synthesis and properties of biodegradable lactic/glycolic acid polymers". In Encyclopedia Handbook of Biomaterials and Bioengineering; Wise et al., eds.; Marcel Dekker: New York, 1995, pp 1151-2000.
91. Lewis, D. H. "Controlled release of bioactive agents from lactide/glycolide polymers". In Biodegradble Polymers as Drug Delivery Systems; Chasin, M.; Langer R, Eds.; Marcel Dekker: New York, 1990, pp 1-41.
92. Park, J. H.; Ye, M.; Park, K. "Biodegradable polymers for microencapsulation of drugs", Molecules 2005, 10, 146-161.
93. Karavelidis, V.; Karavas, E.; Giliopoulos, D.; Papadimitriou, S.; Bikiaris, D. "Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior", Int. J. Nanomedicine. 2011, 6, 3021-3032.